Received: 23 August 2021
Accepted: 14 June 2022
First Online: 25 July 2022
: The study protocol was approved by the institutional review board of the National Cancer Institute, Cairo University, which was in accordance with 2011 Declaration of Helsinki. A written informed consent was obtained from each patient prior enrollment in the study.
: A written informed consent was obtained from the patients for publication.
: Dr Abdel Rahman Zekri is a co-author of this study and an Associate Editor of the journal. He declares competing interest for this submission. He was not involved in handling this manuscript during the submission and review processes. The rest of the authors have no conflict of interest to declare.